Epidemiology and pathogenesis of esophageal cancer, and the possibilities of its prevention;A nyelocsorák kockázati tényezoi és lehetséges genetikai háttere

Orvosi Hetilap

Volumn 150, Issue 9, 2009, Pages 407-413

  Hagymási, Krisztina ^a,b,c   Tulassay, Zsolt ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Semmelweis Egyetem   (Hungary)

Author keywords

Adenocarcinoma; Epidemiology; Esophageal cancer; Pathogenesis; Prevention; Protooncogenes; Risk factors; Squamous cell carcinoma; Tumorsuppressors

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADENOCARCINOMA; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; DIET; ESOPHAGUS CANCER; HUMAN; SMOKING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; ESOPHAGUS DISEASE; ESOPHAGUS TUMOR; FEEDING BEHAVIOR; FRUIT; GENETIC PREDISPOSITION; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; METABOLISM; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL DISEASES; ESOPHAGEAL NEOPLASMS; FOOD HABITS; FRUIT; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OBESITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SURVIVAL RATE;

EID: 64049091919     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2009.28558     Document Type: Article

References (46)

1. Umar, S. B., Fleischer, D. E.: Esophageal cancer: epidemiology, pathogenesis and prevention. Nat. Clin. Pract. Gastroent. Hepa-tol., 2008, 5, 517-526.
2. McCabe, M. L., Dlamini, Z.: The molecular mechanisms of oesophageal cancer. Int. Immunopharmacol., 2005, 5, 1113- 1130.
3. Kuwano, H., Kato, H., Miyazaki, T. és mtsai: Genetic alterations in esophageal cancer. Surg. Today, 2005, 35, 7-18.
4. Elton, E.: Esophageal cancer. Dis. Mon., 2005, 51, 664-684.
5. Trivers, K. F., Sabatino, S. A., Stewart, S. L.: Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int. J. Cancer, 2008, 123, 1422-1428.
6. Cummings, L. C., Cooper, G. S.: Descriptive epidemiology of esophageal carcinoma in the Ohio Cancer Registry. Cancer Detect. Prev., 2008, 32, 87-92.
7. Brown, L. M., Devesa, S. S., Chow, W. H.: Incidence of adenocar-cinoma of the esophagus among white Americans by sex, stage, and age. J. Natl. Cancer. Inst., 2008, 100, 1184-1187.
8. Wu, X., Chen, V. W., Andrews, P. A. és mtsai: Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Caus. Contr., 2007, 18, 585-593.
9. Bosetti, C., Levi, F., Ferlay, J. és mtsai: Trends in oesophageal cancer incidence and mortality in Europe. Int. J. Cancer, 2008, 122, 1118-1129.
10. Vioque J, Barber X, Bolumar F és mtsai, Collaborators (72): Esophageal cancer risk by type of alcohol drinking and smoking: a case-control study in Spain. BMC Cancer, 2008, 8, 221.
11. Fan, Y., Yuan, J. M., Wang, R. és mtsai: Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study. Nutr. Cancer, 2008, 60, 354-363.
12. Hashibe, M., Boffetta, P., Janout, V. és mtsai: Esophageal cancer in Central and Eastern Europe: tobacco and alcohol. Int. J. Cancer, 2007, 120, 1518-1522.
13. Bosetti, C., Gallus, S., Garavello, W. és mtsa: Smoking cessation and the risk of oesophageal cancer: An overview of published studies. Oral Oncol., 2006, 42, 957-964.
14. Pandeya, N., Williams, G. M., Sadhegi, S. és mtsai: Associations of duration, intensity, and quantity of smoking with adenocarci-noma and squamous cell carcinoma of the esophagus. Am. J. Epidemiol., 2008, 168, 105-114.
15. Li, D. P., Dandara, C., Walther, G. és mtsa: Genetic polymorphisms of alcohol metabolising enzymes: their role in susceptibility to oesophageal cancer. Clin. Chem. Lab. Med., 2008, 46, 323-328.
16. Abnet, C. C., Freedman, N. D., Hollenbeck, A. R. és mtsai: A prospective study of BMI and risk of oesophageal and gastric adeno-carcinoma. Eur. J. Cancer, 2008, 44, 465-471.
17. Whiteman, D. C., Sadeghi, S., Pandeya, N. és mtsai; Australian Cancer Study: Combined effects of obesity, acid refl ux and smoking on the risk of adenocarcinomas of the oesophagus. Gut, 2008, 57, 173-180.
18. Smith, M., Zhou, M., Whitlock, G. és mtsai: Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int. J. Cancer, 2008, 122, 1604-1610.
19. Corley, D. A., Kubo, A., Zhao, W.: Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol. Biomarkers Prev., 2008, 17, 352-358.
20. Engeland, A., Tretli, S., Bjørge, T.: Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women. Cancer Caus. Contr., 2004, 15, 837-843.
21. Gallus, S., La Vecchia, C., Levi, F. és mtsai: Leanness and squa-mous cell oesophageal cancer. Ann. Oncol., 2001, 12, 975-979.
22. Wang, J. M., Xu, B., Rao, J. Y. és mtsai: Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur. J. Gastroenterol. Hepatol., 2007, 19, 171-176.
23. Yamaji, T., Inoue, M., Sasazuki, S. és mtsai: Fruit and vegetable consumption and squamous cell carcinoma of the esophagus in Japan: the JPHC study. Int. J. Cancer, 2008, 123, 1935-1940.
24. Yamaji, T., Inoue, M., Sasazuki, S. és mtsai; Japan Public Health Center-based Prospective Study Group: Fruit and vegetable consumption and squamous cell carcinoma of the esophagus in Japan: the JPHC study. Int. J. Cancer, 2008, 123, 1935-1940.
25. Ishikawa, A., Kuriyama, S., Tsubono, Y. és mtsai: Smoking, alcohol drinking, green tea consumption and the risk of esophageal cancer in Japanese men. J. Epidemiol., 2006, 16, 185-192.
26. Rossi, M., Garavello, W., Talamini, R. és mtsai: Flavonoids and risk of squamous cell esophageal cancer. Int. J. Cancer, 2007, 120, 1560-1564.
27. Wu, A. H., Tseng, C. C., Hankin, J. és mtsa: Fiber intake and risk of adenocarcinomas of the esophagus and stomach. Cancer Caus. Contr., 2007, 18, 713-722.
28. Freedman, N. D., Park, Y., Subar, A. F. és mtsai: Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int. J. Cancer, 2007, 121, 2753-2760.
29. Rokkas, T., Pistiolas, D., Sechopoulos, P. és mtsai: Relationship between Helicobacter pylori infection and esophageal neoplasia: a metaanalysis. Clin. Gastroenterol. Hepatol., 2007, 5, 1413- 1417.
30. Zhuo, X., Zhang, Y., Wang, Y. és mtsai: Helicobacter pylori infection and oesophageal cancer risk: association studies via evidence-based metaanalyses. Clin. Oncol. (R. Coll. Radiol.), 2008, 20, 757-762.
31. Ye, W., Held, M., Lagergren, J. és mtsai: Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J. Natl. Cancer Inst., 2004, 96, 388-396.
32. Abdel-Latif, M. M., Windle, H., Terres, A. és mtsai: Helicobacter pylori extract induces nuclear factor-kappa B, activator protein-1, and cyclooxygenase-2 in esophageal epithelial cells. J. Gastroin-test. Surg., 2006, 10, 551-562.
33. Leeuwenburgh, I., Haringsma, J., Van Dekken, H. és mtsai: Long-term risk of oesophagitis, Barrett's oesophagus and oesophageal cancer in achalasia patients. Scand. J. Gastroenterol. Suppl., 2006, 243, 7-10.
34. Zendehdel, K., Nyrén, O., Edberg, A. és mtsa: Risk of Esophageal Adenocarcinoma in Achalasia Patients, a Retrospective Cohort Study in Sweden. Am. J. Gastroenterol.; Epub: 2007, May 3.
35. Fitzgerald, R. C.: Genetics and prevention of oesophageal adeno-carcinoma. Recent Results Cancer Res., 2005, 166, 35-46.
36. Shimada, H., Ochiai, T.: Gene therapy for esophageal squamous cell carcinoma. In Gene Therapy Front. Biosci., 2008, 13, 3364- 3372.
37. Shimada, H., Takeda, A., Shiratori, T. és mtsai: Prognostic sig-nifi cance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma. Cancer, 2002, 94, 1947- 1954.
38. Caravello, W., Negri, E., Talamini, R. és mtsai: Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1390-1393.
39. Sapapti-Biyyani, R. S., Chessler, L., McCain, E. és mtsai: Familial trends of inheritance in gastro esophageal refl ux disease, Barrett's esophagus and Barrett's adenocarcinoma: 20 families. Dis. Esophagus, 2007, 20, 53-57.
40. Hagymási K., Tulassay Zs.: A nyelocsolaphámrá k genetikai és molekuláris háttere és a génterápia lehetoségei. Orv. Hetil., 2007, 148, 1795-1800.
41. de Boer, J. G., Yang, H., Holcroft, J. és mtsa: Chemoprotection against N-nitrosomethylbenzylamine-induced mutation in the rat esophagus. Nutr. Cancer, 2004, 50, 168-173.
42. Stoner, G. D., Wang, L. S., Chen, T.: Chemoprevention of esopha-geal squamous cell carcinoma. Toxicol. Appl. Pharmacol., 2007, 224, 337-349.
43. Stoner, G. D., Chen, T., Kresty, L. A. és mtsai: Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms. Nutr. Cancer, 2006, 54, 33-46.
44. Chen, T., Hwang, H., Rose, M. E. és mtsai: Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cy-clooxygenase-2, inducible nitric oxide synthase, and c-Jun. Cancer Res., 2006, 66, 2853-2859.
45. Limburg, P. J., Wei, W., Ahnen, D. J. és mtsai: Randomized, placebo-controlled, esophageal squamous cell cancer chemopreven-tion trial of selenomethionine and celecoxib. Gastroenterology, 2005, 129, 863-873.
46. Corley, D. A., Kerlikowske, K., Verma, R. és mtsai: Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology, 2003, 124, 47-56.